A detailed history of Algert Global LLC transactions in Geron Corp stock. As of the latest transaction made, Algert Global LLC holds 395,071 shares of GERN stock, worth $1.25 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
395,071
Previous 127,071 210.91%
Holding current value
$1.25 Million
Previous $539,000 232.84%
% of portfolio
0.05%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$4.17 - $4.99 $1.12 Million - $1.34 Million
268,000 Added 210.91%
395,071 $1.79 Million
Q2 2024

Aug 14, 2024

BUY
$3.1 - $5.09 $393,920 - $646,791
127,071 New
127,071 $539,000
Q1 2022

May 16, 2022

BUY
$0.99 - $1.6 $31,671 - $51,185
31,991 New
31,991 $44,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.2B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.